MedPath

Cancer Distress Coach Mobile App Trial

Not Applicable
Completed
Conditions
Posttraumatic Stress Disorder
Cancer
Interventions
Behavioral: Cancer Distress Coach Mobile App
Registration Number
NCT02986152
Lead Sponsor
Duke University
Brief Summary

The Cancer Distress Coach (CDC) mobile app is a symptom management tool for posttraumatic stress disorder (PTSD) in cancer patients and caregivers. Based largely on "PTSD Coach" from the National Center for PTSD, the CDC app was redesigned for both iOS and Android platforms and is tailored specifically to individuals impacted by cancer.

This study aims to evaluate whether CDC app usage influences symptoms of PTSD through a randomized controlled trial (RCT) where subjects are placed into either the intervention group or the wait-listed control group for a period of 8 weeks. The CDC app is available as a free download on the App Store® and on Google Play™.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
569
Inclusion Criteria
  • Have been diagnosed with cancer or are/were a caregiver to someone with cancer
  • Resident of the United States of America
  • Able to read and write English
  • Age ≥ 18 years
Read More
Exclusion Criteria
  • None
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CDC Mobile App TreatmentCancer Distress Coach Mobile AppSubjects who are randomized to the CDC mobile app treatment arm will be asked to perform the app's full suite of intervention tools such as learning about PTSD, assessment, finding support, and mind/body exercises (e.g., guided imagery, meditation, and relaxation exercises) over the entire 8-week study period.
CDC Mobile App Wait-List ControlCancer Distress Coach Mobile AppSubjects who are randomized to the CDC mobile app wait-list control arm will be asked to perform only the learning about PTSD, assessment, and finding support activities for the first 4 weeks. Following completion of the Week-4 questionnaires, subjects will then be asked to additionally perform the mind/body exercises (e.g., guided imagery, meditation, and relaxation exercises) for the duration of the 8-week study period.
Primary Outcome Measures
NameTimeMethod
Change in PTSD symptoms as measured by the PTSD Checklist (PCL-5)Baseline, Week 4, Week 8

The PCL-5 is a 20-item self-report symptom checklist that closely mirrors DSM-5 diagnoses criteria. The instructions will be modified so that symptoms are keyed to the particular traumatic stressor of interest; specifically, subjects will be asked to rate each PTSD symptom in the past 4 weeks with respect to their cancer diagnosis and treatment.

Secondary Outcome Measures
NameTimeMethod
Change in stress management self-efficacy as measured by the Self-efficacy questionnaireBaseline, Week 4, Week 8

The Self-efficacy questionnaire is a 1-item measure of self-efficacy developed by the National Center for PTSD. It rates one's ability to manage the stress of situations reminiscent of the cancer experience on a scale of 0-4, where 0 is not at all able and 4 is extremely able.

Change in distress level as measured by the Distress ThermometerBaseline, Week 4, Week 8

The Distress Thermometer is used to assess psychosocial distress. It consists of a one-item self-report scale from 0-10, where 0 represents no distress and 10 represents extreme distress.

Trial Locations

Locations (1)

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath